INSIGHTS AND RESOURCES
Health care and life sciences deal flow
2021 could mark busiest year yet
INSIGHT ARTICLE |
Authored by RSM US LLP
In years past, the JP Morgan Healthcare Conference, held in mid-January, has heralded sector announcements of large partnerships, joint ventures, and mergers and acquisitions. This year, the health care sector could not even wait until the second full week of the year to kick off an acquisition announcement spree. While we may see investors pull back after last quarter’s investment spree to focus on integrations and operations, or to focus on other industries as they rebalance portfolios, the quick start is an early sign of what promises to be an active year for funding and mergers and acquisitions activity.
Through mid-January, we have seen more than $3.1 billion of announced deals in the health care services sector, largely driven by Centene’s $2.9 billion acquisition of the behavioral health provider Magellan on Jan. 4. Already, this deal represents 82% of last year’s first-quarter deal volume ($3.8 billion). It’s safe to say that year over year, we will see more health care services deal volume in the first quarter than we did last year.
Meanwhile, the pandemic is shining a bright light on the potential of the life sciences arena. The pharmaceutical sector has already exceeded last year’s deal volume in the first quarter by $1.6 billion, due to Bristol Myers Squibb’s blockbuster $11.1 billion acquisition of MyoKardia. Biotech has been off to a slower start this quarter after posting $193.2 billion in 2020, its largest year for deal volume on record. While this year may not be as busy for pharma and biotech as 2020, there are no shortages of therapies that require funding.
Keen observers will note that the data above excludes the acquisition of Change Healthcare by UnitedHealth Group’s Optum for $12.8 billion. Such tangential deals in nonmedical services and health care technology will continue to see activity in 2021. Rock Health estimates that 2020 saw $12 billion in digital health venture funding, which nearly doubles 2019’s $7.4 billion. We expect 2021 will be an even busier year for digital health, given the disruption thrust upon the ecosystem by the pandemic.
Additional tail winds for deal volume across the entire health care ecosystem include reduced political uncertainty, a favorable interest rate environment and vaccination. Deal-makers have a continuously clarifying view of White House health care policy over the next four years, and the threats to the Affordable Care Act seem largely in the rearview mirror.
This improved certainty reduces some risk associated with executing deals. Meanwhile, the Fed has said it intends to keep interest rates low until at least 2023, which will make capital cheaper and deals more attractive. Furthermore, RSM estimates that $4 trillion of economic activity is currently sidelined, waiting to be unleashed once the populace has achieved herd immunity, social distancing requirements relax and businesses can return to full capacity.
These powerful macroeconomic factors will fuel an incredibly active year in health care deal activity.
Call us at +1 213.873.1700, email us at email@example.com or fill out the form below and we'll contact you to discuss your specific situation.
This article was written by RSM US LLP and originally appeared on 2021-01-29.
2020 RSM US LLP. All rights reserved.
RSM US Alliance provides its members with access to resources of RSM US LLP. RSM US Alliance member firms are separate and independent businesses and legal entities that are responsible for their own acts and omissions, and each is separate and independent from RSM US LLP. RSM US LLP is the U.S. member firm of RSM International, a global network of independent audit, tax, and consulting firms. Members of RSM US Alliance have access to RSM International resources through RSM US LLP but are not member firms of RSM International. Visit rsmus.com/about us for more information regarding RSM US LLP and RSM International. The RSM logo is used under license by RSM US LLP. RSM US Alliance products and services are proprietary to RSM US LLP.
Vasquez & Company LLP is a proud member of the RSM US Alliance, a premier affiliation of independent accounting and consulting firms in the United States. RSM US Alliance provides our firm with access to resources of RSM US LLP, the leading provider of audit, tax and consulting services focused on the middle market. RSM US LLP is a licensed CPA firm and the U.S. member of RSM International, a global network of independent audit, tax and consulting firms with more than 43,000 people in over 120 countries.
Our membership in RSM US Alliance has elevated our capabilities in the marketplace, helping to differentiate our firm from the competition while allowing us to maintain our independence and entrepreneurial culture. We have access to a valuable peer network of like-sized firms as well as a broad range of tools, expertise and technical resources.
For more information on how Vasquez & Company LLP can assist you, please call +1 213.873.1700.
Subscribe to receive important updates from our Insights and Resources.